Simultaneous determination of ticarcillin and clavulanate in rabbit serum and tissue cage fluid by liquid chromatography
- PMID: 12954375
- DOI: 10.1016/s1570-0232(03)00456-2
Simultaneous determination of ticarcillin and clavulanate in rabbit serum and tissue cage fluid by liquid chromatography
Abstract
A gradient elution HPLC method with a wavelength switch technique was developed to simultaneously analyze the beta-lactam ticarcillin and the beta-lactamase inhibitor clavulanate in rabbit serum and tissue cage fluid (TCF). A C18 reversed-phase column with a programmable UV detector changing the wavelength from 218 to 254 nm at 9 min was used for chromatographic separation. The mobile phase consisted of acetonitrile, phosphate buffer and tetrabutylammonium hydrogen sulfate by following a gradient elution program at a flow-rate of 1 ml/min. Sample processing was carried out with liquid-liquid extraction. Good linearity, recoveries, precision and accuracy were obtained. The ranges of the standard curves were 1-100 microg/ml for ticarcillin, and 0.2-20 microg/ml for clavulanate. This assay has been successfully applied to analyze ticarcillin and clavulanate in rabbit serum and tissue cage fluid samples from a pharmacokinetic study.
Similar articles
-
Administration of ticarcillin in combination with clavulanic acid intravenously and intrauterinely to clinically normal oestrous mares.J Vet Pharmacol Ther. 2000 Dec;23(6):373-8. doi: 10.1046/j.1365-2885.2000.00297.x. J Vet Pharmacol Ther. 2000. PMID: 11168915
-
Simultaneous analysis of piperacillin and tazobactam in rabbits: application to pharmacokinetic study.Biomed Chromatogr. 2005 Jan;19(1):99-106. doi: 10.1002/bmc.425. Biomed Chromatogr. 2005. PMID: 15484223
-
A sensitive assay of amoxicillin in mouse serum and broncho-alveolar lavage fluid by liquid-liquid extraction and reversed-phase HPLC.J Pharm Biomed Anal. 2005 Sep 15;39(3-4):648-52. doi: 10.1016/j.jpba.2005.04.021. J Pharm Biomed Anal. 2005. PMID: 15935600
-
Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.J Antimicrob Chemother. 2004 Feb;53(2):297-304. doi: 10.1093/jac/dkh057. Epub 2004 Jan 16. J Antimicrob Chemother. 2004. PMID: 14729755
-
Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.Pharmacotherapy. 2000 Sep;20(9 Pt 2):213S-218S; discussion 224S-228S. doi: 10.1592/phco.20.14.213s.35045. Pharmacotherapy. 2000. PMID: 11001328 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical